Reference health
HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: evidence from genetic analysis and randomised trials
61183-1/badge.svg){kind=icon}
37/37 checkable references clean · checked 2026-07-23
Every reference with a DOI in the deposited reference list resolved to a known work in Crossref or DataCite at the dated check, and none carried a retraction, withdrawal, or removal notice.
2 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.
The 37 checked references that resolve
resolves10.1016/S0140-6736(10)61350-5
Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials
resolves10.1016/j.amjmed.2007.06.033
Statin Therapy in Stroke Prevention: A Meta-analysis Involving 121,000 Patients
resolves10.1016/S0140-6736(12)60367-5
The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials
resolves10.1016/S0140-6736(08)60104-X
Efficacy of cholesterol-lowering therapy in 18 686 people with diabetes in 14 randomised trials of statins: a meta-analysis
resolves10.1016/S0140-6736(09)61965-6
Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials
resolves10.1001/jama.2011.860
Risk of Incident Diabetes With Intensive-Dose Compared With Moderate-Dose Statin Therapy
resolves10.1136/bmj.f2610
Risk of incident diabetes among patients treated with statins: population based study
resolves10.1016/j.amjcard.2012.12.037
Meta-Analysis of Impact of Different Types and Doses of Statins on New-Onset Diabetes Mellitus
resolves10.1093/ije/dyg070
‘Mendelian randomization’: can genetic epidemiology contribute to understanding environmental determinants of disease?*
resolves10.1016/S0140-6736(12)60110-X
The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis
resolves10.1016/0140-6736(91)93068-K
Health inequalities among British civil servants: the Whitehall II study
resolves10.1371/journal.pone.0003583
Concept, Design and Implementation of a Cardiovascular Gene-Centric 50 K SNP Array for Large-Scale Genomic Association Studies
resolves10.1038/ng.75
Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans
resolves10.1371/journal.pmed.0050177
Mendelian Randomisation and Causal Inference in Observational Epidemiology
resolves10.1001/jama.288.23.2998
Major Outcomes in Moderately Hypercholesterolemic, Hypertensive Patients Randomized to Pravastatin vs Usual Care: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT-LLT)
resolves10.1001/jama.292.11.1307
Early Intensive vs a Delayed Conservative Simvastatin Strategy in Patients With Acute Coronary Syndromes
resolves10.1038/ng.686
Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index
resolves10.1038/ng.2385
Large-scale association analyses identify new loci influencing glycemic traits and provide insight into the underlying biological pathways
resolves10.1038/ng.2383
Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes
resolves10.1371/journal.pgen.1002793
The Metabochip, a Custom Genotyping Array for Genetic Studies of Metabolic, Cardiovascular, and Anthropometric Traits
resolves10.1016/j.ajhg.2013.12.014
Causal Effects of Body Mass Index on Cardiometabolic Traits and Events: A Mendelian Randomization Analysis
resolves10.1016/j.jacc.2009.10.053
Atorvastatin Causes Insulin Resistance and Increases Ambient Glycemia in Hypercholesterolemic Patients
resolves10.1016/j.diabres.2009.10.008
Differing effect of statins on insulin sensitivity in non-diabetics: A systematic review and meta-analysis
resolves10.1056/NEJMoa0807646
Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein
resolves10.1007/s00125-008-1179-5
Atorvastatin in Factorial with Omega-3 EE90 Risk Reduction in Diabetes (AFORRD): a randomised controlled trial
resolves10.1016/S0140-6736(12)61190-8
Cardiovascular benefits and diabetes risks of statin therapy in primary prevention: an analysis from the JUPITER trial
The 2 references without a DOI — listed, not checked
no DOI — not checked10.1016/S0140-6736(14)61183-1_bib5
no DOI — not checkedHigh-dose atorvastatin associated with worse glycemic control: a PROVE-IT TIMI 22 substudy
What this badge says. CiteStamped means the CHECKABLE references of this
work were clean at the dated check: each resolved to a known work in a public registry, and none
carried a retraction notice at that time. It says nothing about the quality, findings,
or importance of the work itself, and nothing about references deposited without a DOI.
checked 2026-07-23 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record
Embed this badge
Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.
<a href="https://citestamp.com/citestamped/10.1016/s0140-6736(14)61183-1"><img src="https://citestamp.com/citestamped/10.1016/s0140-6736(14)61183-1/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[61183-1/badge.svg)](https://citestamp.com/citestamped/10.1016/s0140-6736(14)61183-1)